About IntelliCyt
IntelliCyt is a company based in Albuquerque (United States) founded in 2006 was acquired by Sartorius in June 2016.. IntelliCyt has raised $13.82 million across 4 funding rounds from investors including Sartorius, Oxford Finance and New Mexico Community Capital. IntelliCyt offers products and services including Octet® R2, Ambr® 15 Cell Culture, Sterisart® Universal Pump, and iQue® System. IntelliCyt operates in a competitive market with competitors including Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others.
- Headquarter Albuquerque, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sartorius Ag
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntelliCyt
IntelliCyt offers a comprehensive portfolio of products and services, including Octet® R2, Ambr® 15 Cell Culture, Sterisart® Universal Pump, and iQue® System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for biolayer interferometry in protein analysis
Multi-parallel system for cell culture in research
Tool for sterility testing in pharmaceuticals
Instrument for cell-based assays in screening
Funding Insights of IntelliCyt
IntelliCyt has successfully raised a total of $13.82M across 4 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $2 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Debt – Venture — $2.0M
-
First Round
First Round
(06 May 2013)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2015 | Amount | Debt – Venture - IntelliCyt | Valuation |
investors |
|
| Jul, 2015 | Amount | Series A - IntelliCyt | Valuation | Arboretum Ventures | |
| Jun, 2014 | Amount | Debt – Venture - IntelliCyt | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IntelliCyt
IntelliCyt has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Sartorius, Oxford Finance and New Mexico Community Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location | |
|
Health-focused venture capital investments are made in US sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IntelliCyt
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IntelliCyt
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intellicyt Comparisons
Competitors of IntelliCyt
IntelliCyt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytek Biosciences, Accuri Cytometers, ACEA Biosciences, Bioaffinity technologies and NanoFCM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Advanced flow cytometry systems are manufactured for research applications.
|
|
| domain | founded_year | HQ Location |
Compact flow cytometers for cell analysis are developed and provided.
|
|
| domain | founded_year | HQ Location |
Instruments for life science research are developed and marketed.
|
|
| domain | founded_year | HQ Location |
IVD platforms are developed to detect and target cancer cells.
|
|
| domain | founded_year | HQ Location |
Offers advanced tools for nanoparticle analysis in biotechnology and healthcare.
|
|
| domain | founded_year | HQ Location |
Instrumentation for cell and protein analysis is developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intellicyt
Frequently Asked Questions about IntelliCyt
When was IntelliCyt founded?
IntelliCyt was founded in 2006 and raised its 1st funding round 7 years after it was founded.
Where is IntelliCyt located?
IntelliCyt is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Is IntelliCyt a funded company?
IntelliCyt is a funded company, having raised a total of $13.82M across 4 funding rounds to date. The company's 1st funding round was a Debt – Venture of $4M, raised on May 06, 2013.
What does IntelliCyt do?
Screening solutions for researchers and biopharmaceutical companies are developed by IntelliCyt, founded in 2006 in Albuquerque, United States. The iQue flow cytometer platform is utilized for cell-based and bead-based assays, with associated software and reagents also supplied. Operations focus on the biotechnology sector, supporting high-throughput screening in drug discovery and research applications.
Who are the top competitors of IntelliCyt?
IntelliCyt's top competitors include Cytek Biosciences, Bioaffinity technologies and Accuri Cytometers.
What products or services does IntelliCyt offer?
IntelliCyt offers Octet® R2, Ambr® 15 Cell Culture, Sterisart® Universal Pump, and iQue® System.
Who are IntelliCyt's investors?
IntelliCyt has 6 investors. Key investors include Sartorius, Oxford Finance, New Mexico Community Capital, Arboretum Ventures, and Prolog Ventures.